FIBROTECH THERAPEUTICS
Fibrotech Therapeutics develops and offers novel drug candidates for the treatment of fibrosis in chronic conditions. It develops drugs for kidney diseases, diabetics, heart failure, pulmonary fibrosis, and arthritis. Founded in 2006, Fibrotech Therapeutics is based in Wonga Park, Australia.
FIBROTECH THERAPEUTICS
Social Links:
Industry:
Education Medical Therapeutics
Founded:
2006-01-01
Address:
Wonga Park, Victoria, Australia
Country:
Australia
Website Url:
http://www.fibrotech.com.au
Total Employee:
11+
Status:
Closed
Total Funding:
7.27 M AUD
Technology used in webpage:
Domain Not Resolving
Current Advisors List
Investors List
Uniseed Ventures
Uniseed Ventures investment in Series A - Fibrotech Therapeutics
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Series A - Fibrotech Therapeutics
Brandon Capital Partners
Brandon Capital Partners investment in Series A - Fibrotech Therapeutics
More informations about "Fibrotech Therapeutics"
12. Fibrotech - AusBiotech Ltd
Fibrotech was seeded with capital from the Medical Research Commericalisation Fund (MRCF), Brandon Capital and Uniseed to advance its development program to completion of a Phase I …See details»
Fibrotech Therapeutics - Crunchbase Company Profile & Funding
Fibrotech Therapeutics develops and offers novel drug candidates for the treatment of fibrosis in chronic conditions. It develops drugs for kidney diseases, diabetics, heart failure, pulmonary …See details»
Fibrotech | Uniseed
Fibrotech is a spin-out of the University of Melbourne that developed drugs to treat fibrosis based on the work of Professor Darren Kelly. In April 2014, Fibrotech reached an agreement with Shire Pharmaceuticals, a global specialty …See details»
Fibrotech Therapeutics - PitchBook
Fibrotech Therapeutics General Information Description. Provider of drugs intended for the treatment of fibrosis associated with diabetic nephropathy. The company develops and …See details»
Fibrotech Therapeutics Pty Ltd. - Drug pipelines, Patents ... - Patsnap
Explore Fibrotech Therapeutics Pty Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, Drug:Asengeprast. ... The statistics for drugs in the Pipeline is …See details»
Fibrotech Therapeutics Pty Ltd - Company Profile and News
Fibrotech Therapeutics Pty Ltd. operates as a clinical stage biopharmaceutical company. The Company develops novel drug candidates to treat the fibrosis prevalent in chronic conditions, …See details»
Fibrotech Therapeutics - Products, Competitors, Financials, …
Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). Use the CB Insights …See details»
Fibrotech acquired by Shire for US$75M plus milestones
May 1, 2014 Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that it has reached an agreement with Shire plc (LSE: SHP, …See details»
Fibrotech Therapeutics Pty Ltd - VentureRadar
" Fibrotech Therapeutics Pty Ltd is a start-up company from St. Vincent's Hospital and the University of Melbourne that is developing novel drug candidates for the treatment of the …See details»
Fibrotech | Biotechnology - The Pharmaletter
Fibrotech Therapeutics is an Australian clinical stage biopharmaceutical company developing novel drug candidates for the treatment of the fibrosis prevalent in chronic conditions such as …See details»
Fibrotech acquired by Shire for US$75M plus milestones
May 1, 2014 Melbourne, Australia- 2nd May 2014 – Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with …See details»
Australia makes its mark in biotechnology - Nature
May 9, 2018 Australia’s biotechnology sector boasts a series of record-breaking deals in recent years. May 2014: Irish pharma group Shire buys Fibrotech and its innovative fibrosis …See details»
Fibrotech Therapeutics - Science Meets Business
Mar 9, 2016 Fibrotech was sold to global specialty biopharmaceutical company Shire in 2014 for an upfront US$75 million and further milestone payments of US$482.5 million. In May 2015, …See details»
Fibrotech bought by Shire for at least $81m - labonline.com.au
Melbourne-based biopharma Fibrotech has agreed to be bought out by Shire for an initial US$75 million ($80.9 million).. The deal, which requires the approval of the Foreign Investment …See details»
Shire acquires Fibrotech for $75M - CenterWatch
May 2, 2014 Shire, a global specialty biopharmaceutical company, has acquired Fibrotech, an Australian biopharmaceutical company developing a new class of drugs associated with …See details»
Shire Acquires Fibrotech For US$75 Million - Asian Scientist …
AsianScientist (May 15, 2014) – Better treatments for fibrosis sufferers is on the horizon following a global drugmaker’s decision to buy the University of Melbourne-affiliated biopharmaceutical …See details»
Precision medicine with new drugs that stop fibrosis - Research
The outcome. Precision medicine company Certa Therapeutics launched in June 2018 to develop drugs for patients with fibrosis. Lead drug FT011 is ready for Phase III clinical trials, while …See details»
Fibrotech
FibroTech Acoustic Panels can be installed both as a ceiling and on a wall. The acoustic panels are made of MDF and real wood veneer, which gives them a very beautiful look with varying …See details»
Fibrotech - Fibrotech
FibroTech træbetonplader har brandsikrede egenskaber, som er afgørende for en passiv brandbeskyttelse af konstruktioner. For eksempel er et højt smeltepunkt og en lav …See details»
Endoscope Repair Services, Cleaning & Sales | Fibertech
Fibertech is the leading multi-OEM service provider of high quality, cost-effective, reliable endoscope repair services and related medical devices.See details»